DUKE UNIVERSITY
Gene therapy targeting CFH and lipoprotein dynamics in AMD
Gene therapy targeting CFH and lipoprotein dynamics in AMD is a funding opportunity from DUKE UNIVERSITY, up to 682606, closing June 30, 2028.
Jun 30, 2028
(700d left)Overview
Gene therapy targeting CFH and lipoprotein dynamics in AMD ABSTRACT Age-related macular degeneration (AMD) is the most common cause of irreversible blindness among the elderly in industrialized countries, and there are no treatments for the majority of patients. Early hallmarks of AMD are the formation of lipid- and…